Suppr超能文献

GB病毒B型RNA依赖的RNA聚合酶的酶活性

Enzymatic activities of the GB virus-B RNA-dependent RNA polymerase.

作者信息

Ranjith-Kumar C T, Santos Jan Lee, Gutshall Lester L, Johnston Victor K, Lin-Goerke Juili, Kim Min-Ju, Porter David J, Maley Derrick, Greenwood Cathy, Earnshaw David L, Baker Audrey, Gu Baohua, Silverman Carol, Sarisky Robert T, Kao Cheng

机构信息

Department of Biology, Indiana University, Bloomington, IN 47405, USA.

出版信息

Virology. 2003 Aug 1;312(2):270-80. doi: 10.1016/s0042-6822(03)00247-2.

Abstract

The GB virus-B (GBV-B) nonstructural protein 5B (NS5B) encodes an RNA-dependent RNA polymerase (RdRp) with greater than 50% sequence similarity to the hepatitis C virus (HCV) NS5B. Recombinant GBV-B NS5B was reported to possess RdRp activity (W. Zhong et al., 2000, J. Viral Hepat. 7, 335-342). In this study, the GBV-B RdRp was examined more thoroughly for different RNA synthesis activities, including primer-extension, de novo initiation, template switch, terminal nucleotide addition, and template specificity. The results can be compared with previous characterizations of the HCV RdRp. The two RdRps share similarities in terms of metal ion and template preference, the abilities to add nontemplated nucleotides, perform both de novo initiation and extension from a primer, and switch templates. However, several differences in RNA synthesis between the GBV-B and HCV RdRps were observed, including (i) optimal temperatures for activity, (ii) ranges of Mn(2+) concentration tolerated for activity, and (iii) cation requirements for de novo RNA synthesis and terminal transferase activity. To assess whether the recombinant GBV-B RdRp may represent a relevant surrogate system for testing HCV antiviral agents, two compounds demonstrated to be active at nanomolar concentrations against HCV NS5B were tested on the GBV RdRp. A chain terminating nucleotide analog could prevent RNA synthesis, while a nonnucleoside HCV inhibitor was unable to affect RNA synthesis by the GBV RdRp.

摘要

GB病毒B(GBV-B)非结构蛋白5B(NS5B)编码一种依赖RNA的RNA聚合酶(RdRp),与丙型肝炎病毒(HCV)NS5B的序列相似性超过50%。据报道,重组GBV-B NS5B具有RdRp活性(W. Zhong等人,2000年,《病毒性肝炎杂志》7,335 - 342)。在本研究中,对GBV-B RdRp的不同RNA合成活性进行了更全面的检测,包括引物延伸、从头起始、模板切换、末端核苷酸添加和模板特异性。结果可与先前对HCV RdRp的表征进行比较。这两种RdRp在金属离子和模板偏好、添加非模板核苷酸的能力、从头起始和从引物延伸以及切换模板方面具有相似性。然而,观察到GBV-B和HCV RdRp在RNA合成方面存在一些差异,包括(i)活性的最佳温度,(ii)活性耐受的Mn(2+)浓度范围,以及(iii)从头RNA合成和末端转移酶活性的阳离子需求。为了评估重组GBV-B RdRp是否可能代表一个用于测试HCV抗病毒药物的相关替代系统,对两种已证明在纳摩尔浓度下对HCV NS5B有活性的化合物在GBV RdRp上进行了测试。一种链终止核苷酸类似物可以阻止RNA合成,而一种非核苷HCV抑制剂无法影响GBV RdRp的RNA合成。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验